Similar to the findings for MRS-treated ulcerative colitis [47] or autoimmune hepatitis [16] and in carbon tetrachloride-induced liver injury [53], CH4 also attenuated the lipopolysaccharide (LPS)-induced activation of MAPKs and NF-κB [56]. This evidence concerns the gene NFKB1 and ulcerative colitis.